Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review

Por Borow, Kenneth M., Mason, R. Preston, Vijayaraghavan, Krishnaswami
Publicado no Cardiorenal Med (2017)

Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure: A Review of Biological Plausibility and Implementation of Flexible Clinical Trial Design

Por Borow, Kenneth M., Yaroshinsky, Alex, Greenberg, Barry, Perin, Emerson C.
Publicado no Circ Res (2019)

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial

Por JASKI, BRIAN E., JESSUP, MARIELL L., MANCINI, DONNA M., CAPPOLA, THOMAS P., PAULY, DANIEL F., GREENBERG, BARRY, BOROW, KENNETH, DITTRICH, HOWARD, ZSEBO, KRISZTINA M., HAJJAR, ROGER J.
Publicado em 2009

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial

Por JASKI, BRIAN E., JESSUP, MARIELL L., MANCINI, DONNA M., CAPPOLA, THOMAS P., PAULY, DANIEL F., GREENBERG, BARRY, BOROW, KENNETH, DITTRICH, HOWARD, ZSEBO, KRISZTINA M., HAJJAR, ROGER J.
Publicado no Circulation (2011)